The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2032

Conditions
Ovarian CancerDifferentiatingDiagnosis
Interventions
DIAGNOSTIC_TEST

Fragmentomics

The fragmentation patterns of cfDNA fragments in plasma and the uneven coverage of the genome can indirectly reflect the state of gene expression regulation in vivo. Its characteristics mainly include copy number variation (CNV), Nucleosome footprint, fragment length and motif. Fragomics relies on WGS (Whole Genome Sequencing), and the target covers the whole Genomics level. Thus, the cfDNA Fragmentomics testing can help differentiation and early diagnosis.

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT05931055 - The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter